瘤微环境中的T细胞衰老
Lihaoyun Huang1, Cangang Zhang2, Aimin Jiang3
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Cancer immunology research
|April 15, 2025
概括
在瘤微环境 (TME) 中的T细胞衰老会损害抗瘤免疫力和免疫疗法的有效性. 向衰老的T细胞提供了一个有希望的策略,以改善癌症治疗结果和患者预后.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 在瘤微环境 (TME) 中,T细胞衰老很普遍.
- 它是由瘤抗原,代谢变化和炎症引发的.
- 衰老的T细胞促进免疫抑制的TME,阻碍抗瘤反应.
研究的目的:
- 探索瘤中T细胞衰老的原因.
- 检查T细胞衰老与癌症预后之间的关系.
- 评估向T细胞衰老,以改善癌症免疫疗法.
主要方法:
- 对癌症T细胞衰老现有文献的综述.
- 对TME中T细胞衰老促成的途径的分析.
- 研究老化的T细胞对免疫监测和免疫治疗的影响.
主要成果:
- 衰老的T细胞显示基因组不稳定性,代谢功能障碍和表观遗传变化.
- 衰老的T细胞和其他免疫细胞之间的交叉交谈会使免疫抑制的TME恶化.
- T细胞衰老与预后不佳和免疫疗法疗效降低有关.
结论:
- T细胞衰老是瘤进展和免疫逃避的一个关键因素.
- 准T细胞衰老机制提供了一个新的治疗途径.
- 调节T细胞衰老可以增强免疫疗法并改善患者的治疗结果.
相关概念视频
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
T Cell Activation and Clonal Selection
544
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
544
Cytotoxic T Cells-mediated Immune Response
736
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
736
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K


